PAULA CASTILLO-MORFIN: Open Payments
NPI 1760137442 · TAMPA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$673 in 26 payments from 5 companies in 2025. Trend: 2023 $539 · 2024 $610 · 2025 $673
Food & beverage: $617Education: $56
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 13 | $377 |
| Regeneron Healthcare Solutions, Inc. | 7 | $165 |
| Optinose US, Inc. | 4 | $84 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $28 |
| Paratek Pharmaceuticals, Inc. | 1 | $19 |
Products named: NUCALA, DUPIXENT, Xhance, NEFFY.
Industry payments across FL — which companies pay providers there.
